Prevalence of eNOS Glu298Asp polymorphism in healthy volunteers from a region of northern India

Community Genetics

Volumn 8, Issue 3, 2005, Pages 180-183

  Srivastava, Kamna ^a   Biswas, Utpal Kumar ^a   Narang, Rajeev ^a   Varghese, Joji Jacob ^a   Das, Nibhriti ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Coronary artery disease; Endothelial nitric oxide synthase; Essential hypertension; Nitric oxide

Indexed keywords

ASPARTIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMIC ACID;

ADULT; ALLELE; ARTICLE; ASIAN; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INDIA; INDIAN; JAPAN; KOREA; MALE; MASS MEDIUM; NORMAL HUMAN; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX RATIO; VOLUNTEER;

AMINO ACID SUBSTITUTION; ASPARTIC ACID; DNA; ELECTROPHORESIS, AGAR GEL; GENOTYPE; GLUTAMIC ACID; HETEROZYGOTE DETECTION; HOMOZYGOTE; HUMANS; INDIA; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, SINGLE NUCLEOTIDE; RESTRICTION MAPPING;

EID: 23944496581     PISSN: 14222795     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086761     Document Type: Article

References (20)

1. Radomski MW, Palmer RM, Moncada S: Endogenous nitric oxide inhibits human platelet adhesion to vascular adhesion to vascular endothelium. Lancet 1987;ii:1057-1058.
2. Nassar BA, Bevin LD, Johnstone DE, O'Neill BJ, Bata IR, Kirkland SA, Title LM: Relationship of the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and early onset of coronary artery disease. J Am Heart 1987;142:586-589.
3. Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y, Nakayama M, Kamitani S, Harada M, Ishikawa M, Kuwahara K, Ogawa E, Hamanaka I, Takahashi N, Kaneshige T, Teraoka H, Akamizu T, Azuma N, Yoshimasa T, Itoh H, Masuda I, Yasue H, Nakao K: Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998;3:23-28.
4. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, Haydock S, Hopper RV, Stephens NG, O'Shaughnessy KM, Bown MJ: A common variant of the endothelial nitric oxide synthase (Glu298Asp) is a major risk factor for coronary artery disease in the UK. Circulation 1999;100:1515-1520.
5. Kato N, Sugiyama T, Morita H, Nabika T, Kurihara H, Yamori Y, Yazaki Y: Lack of evidence for association between the endothelial nitric oxide synthase gene and hypertension. Hypertension 1999;33:933-936.
6. Hibi K, Ishigami T, Tamura K, Mizushima S, Nyui N, Fugita T, Ochiai H, Kosuge M, Watanabe Y, Yoshii Y: Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 1998;32:521-526.
7. Philip I, Plantefeve G, Vuillaumier-Barrot S, Vicat E, LeMarie C, Henrion D, Poirier O, Levy BI, Desmonts JM, Durand G, Bennessiano J: G894T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenylephrine. Circulation 1999;99:3096-3098.
8. Liyou N, Simons L, Friedlander Y, Simons J, McCallum J, O'Shaughnessy K, Johnson A: Coronary artery disease is not associated with the E298D variant of the constitutive endothelial nitric oxide synthase gene. Clin Genet 1998;54:528-529.
9. Yoshimura T, Chowdhury FA, Yoshimura M, Okamura H: Genetic and environmental contributions to severe preeclempsia: Lack of association with the endothelial nitric oxide synthase Glu298Asp variant in a developing country. Gynecol Obstet Invest 2003;56:10-13.
10. Gupta R, Gupta VP: Meta analysis of coronary heart disease prevalence in India. Indian Heart J 1996;48:241-245.
11. Enas EA, Dhawan J, Petkar S: Coronary artery disease in Asian Indians: Lessens learnt and the role of lipoprotein(a). Indian Heart J 1997:49:25-34.
12. Bahl VK, Prabhakaran D, Karthikeyan G: Coronary artery disease in Indians. Indian Heart J 2001;53:707-713.
13. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acid Res 1988;16:1215.
14. Armitage P, Berry G: Statistical Methods for Medical Research, ed 3. Oxford, Blackwell Scientific, 1994, pp 132-144.
15. Rankinen T, Rice T, Perusse L, Chagnon YC, Gagnon J, Leon AS, Wilmore JH, Rao DC, Bonchard C: NOS3 Glu298Asp genotype and blood pressure response to endurance training: the HERITAGE family study. Hypertension 2000;36:885-889.
16. Yoon Y, Song J, Hong SH, Kim JQ: Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin Chem 2000;46:1626-1630.
17. Tesauro M, Thomspon WC, Rogliani P, Qi L, Chaudhary PP, Moss J: Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: Cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci USA 2000;97:2832-2835.
18. Mishra S, Narang R, Thatai D, Goel A, Gupta D, Rajani M, Reddy KS, Manchanda SC: Angiographic prevalence of coronary artery disease in native Indians: Comparison with western studies. Indian Heart J 1998;50:650.
19. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, Sugiyma S, Kugiyama K, Ogawa Y, Saito Y, Miyamoto Y, Nakao K: A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 1998;103:65-69.
20. Lacolley P, Gautier S, Poirier O, Pannier B, Cambien F, Benetos A: Nitric oxide synthase gene polymorphisms, blood pressure and aortic stiffness in normotensive and hypertensive subjects. J Hypertens 1998;16:31-35.